Mutual of America Capital Management LLC Purchases 2,689 Shares of Centene Co. (NYSE:CNC)

Mutual of America Capital Management LLC raised its position in Centene Co. (NYSE:CNC) by 2.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 99,130 shares of the company’s stock after buying an additional 2,689 shares during the period. Mutual of America Capital Management LLC’s holdings in Centene were worth $7,356,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of CNC. Coppell Advisory Solutions Corp. acquired a new position in shares of Centene in the 4th quarter valued at $25,000. Turtle Creek Wealth Advisors LLC acquired a new position in shares of Centene in the 4th quarter valued at $25,000. Operose Advisors LLC acquired a new position in shares of Centene in the 3rd quarter valued at $25,000. ST Germain D J Co. Inc. acquired a new position in shares of Centene in the 2nd quarter valued at $26,000. Finally, OFI Invest Asset Management acquired a new position in shares of Centene in the 3rd quarter valued at $26,000. 93.63% of the stock is currently owned by institutional investors.

Centene Price Performance

Shares of NYSE CNC opened at $70.73 on Friday. The stock has a market capitalization of $37.83 billion, a price-to-earnings ratio of 14.41, a PEG ratio of 0.89 and a beta of 0.38. The business has a 50-day moving average of $76.80 and a 200-day moving average of $74.44. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.11 and a quick ratio of 1.11. Centene Co. has a fifty-two week low of $60.83 and a fifty-two week high of $81.42.

Centene (NYSE:CNC) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Centene had a return on equity of 14.26% and a net margin of 1.75%. The business had revenue of $39.46 billion during the quarter, compared to analysts’ expectations of $36.16 billion. During the same quarter last year, the company posted $0.86 earnings per share. Centene’s quarterly revenue was up 11.0% on a year-over-year basis. As a group, sell-side analysts predict that Centene Co. will post 6.75 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Lori Jean Robinson sold 10,000 shares of Centene stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the completion of the transaction, the director now owns 11,455 shares in the company, valued at $886,731.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Centene news, President Kenneth J. Fasola sold 12,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total transaction of $900,840.00. Following the completion of the sale, the president now directly owns 235,365 shares in the company, valued at $17,668,850.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Lori Jean Robinson sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total transaction of $774,100.00. Following the sale, the director now owns 11,455 shares of the company’s stock, valued at $886,731.55. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CNC shares. Stephens reaffirmed an “equal weight” rating and set a $85.00 price objective (down previously from $92.00) on shares of Centene in a research note on Thursday, March 21st. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 price objective on shares of Centene in a research note on Thursday, April 4th. UBS Group raised their price objective on Centene from $72.00 to $79.00 and gave the stock a “neutral” rating in a research note on Thursday, December 21st. Barclays initiated coverage on Centene in a research note on Wednesday, March 6th. They set an “overweight” rating and a $101.00 price objective on the stock. Finally, StockNews.com downgraded Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, March 28th. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $85.08.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.